Psychiatrist.com - Home of The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders

Just Published

Voice of the Patient

September 9, 2026

Discusses a recent study by Bayrampour et al of the use of speech features for prediction of MDD and GAD during pregnancy.

Mark Opler

Original Research

Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages

September 9, 2026

The prevalence of probable perinatal depression was comparable to that in US women, demonstrating the app’s ability to identify perinatal depression.

Kay Roussos-Ross, Rhea Parimoo, Nayana A. Sojin, et al

Original Research

Using Speech to Predict MDD and GAD During Pregnancy

September 9, 2026

Influential speech features for prediction of MDD and GAD during pregnancy were similar to those in the general population.

Hamideh Bayrampour, Joana Amorim, Joao Pimentel, et al

Rounds in the General Hospital

When Medical Mistakes Leave Lasting Damage

September 8, 2026

Elements of disclosures and apologies (tone and nonverbal communication) play an important role after a medical error has occurred, and clinicians should allow ample time for discussion so that…

Daniel Powell, David Wilkerson, Gregg Robbins-Welty, et al

Case Report

When Obsession and Psychosis Become Indistinguishable

September 8, 2026

Differentiating obsessions from delusions is essential for accurate diagnosis and management, as comorbid obsessive-compulsive symptoms in schizophrenia complicate treatment and may influence cognitive and affective outcomes.

Marta Rebelo, Patrícia Baronet, José Abrantes, et al

Podcast

The Regulatory Maze of Ketamine and Psychedelics with Benjamin Brody, MD

September 8, 2026

Benjamin Brody, MD, discusses ketamine’s REMS-regulated future, esketamine safety, dysphoric dissociation, and what psilocybin approval means for psychiatry.

Benjamin Brody, Ben Everett

Explore
By Topic

View all topics

Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychedelics Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Recent Features

Neural network illustration exploring psychedelic therapy mechanisms

Portrait of Dr. David T. Liebers discussing metabolism in psychiatry

Promotional graphic shows Biostats Made Simple by Dr. Andrade, promoting mastering statistics for clinical decisions.

Original Research

Evaluation of Sexual Function With Adjunctive Lumateperone in Major Depressive Disorder

September 2, 2026

Adjunctive lumateperone 42 mg did not worsen sexual functioning and was not associated with treatment-related sexual dysfunction.

Anita H. Clayton, Willie R. Earley, Susan G. Kozauer, et al

Original Research

Intrusive PTSD Symptoms and Elevated CRP in World Trade Center Responders

September 1, 2026

Intrusive PTSD symptoms may contribute to systemic inflammation in WTC responders, thus targeting both PTSD symptoms and obesity/dyslipidemia may help mitigate risk for elevated systemic inflammation.

Sarah B. Rutter, Abigail B. Collins, Marin Kautz, et al

Original Research

Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.

Dara E. Babinski, Wen-Jan Tuan

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals. Now featuring The JCP Podcast: conversations with experts exploring the research shaping clinical care. <span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

EXPLORE JCP

Meta-Analysis

Pharmacotherapies for Co-Occurring Stimulant Use Disorder and ADHD

August 31, 2026

Stimulant-based pharmacotherapies, particularly higher-dose methylphenidate and mixed amphetamine salts, were associated with superior outcomes for both stimulant-use indicators and ADHD symptoms.

Henrique N. P. Oliva, Alejandra Pulido-Saavedra, Alisson M. Paredes Naveda, et al

Clinical and Practical Psychopharmacology

Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality

August 31, 2026

Evidence on the association of ECT with lower risk of short- and long-term all-cause mortality, nonsuicide mortality, and suicide mortality is reviewed.

Chittaranjan Andrade

Explore Special Sections from JCP

Focus on Childhood and Adolescent Mental Health Early Career Psychiatrists Focus on Geriatric Psychiatry Focus on Psychosis Focus on Psychotherapy Focus on Suicide Focus on Women’s Mental Health

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles